肺炎球菌疫苗

  • 网络pneumococcal;Pneumococcal Vaccine;Prevnar;prevenar
肺炎球菌疫苗肺炎球菌疫苗
  1. 但Siriwardena医生认为这样的结果令人意外,因为最近的一项研究提出了肺炎球菌疫苗的潜在保护作用。

    This result could be considered somewhat surprising , according to Siriwardena , as one recent study did suggest a potential protective effect of the pneumococcal vaccine .

  2. 因此,肺炎球菌疫苗在最弱势的人群中对拯救生命将是尤其重要的。

    The pneumococcal vaccine will therefore be particularly important to save lives in the most disadvantaged populations .

  3. 全球疫苗免疫联盟和八国集团领导人已经提议,把肺炎球菌疫苗作为先进市场委托模式试验项目的一部分。

    The GAVI Alliance and G8 leaders have proposed including pneumococcal vaccines as part of an AMC pilot run .

  4. 但肺炎球菌疫苗的情况可能不同,病人可能并不迫切需要接种疫苗。

    But pneumococcal vaccine might be a different situation and one in which there might be no urgency to vaccinate .

  5. 目前肺炎球菌疫苗在全球范围内大规模的预防接种,使得病菌的流行病学发生改变。

    Recently , the pneumococcal vaccines in the global scope of large-scale immunization have caused germs epidemiology to be changed .

  6. 肺炎球菌疫苗免疫接种对反复发作的急性中耳炎患儿生活质量的影响:一项随机对照试验

    Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media : A randomized , controlled trial

  7. 最重要的是,试验表明,即使在非洲农村的环境中,接种肺炎球菌疫苗也可预防许多此类严重感染。

    Most importantly , it demonstrates that pneumococcal vaccination can prevent many of these serious infections even in a rural African setting .

  8. 他说一个目标将是把肺炎球菌疫苗的成本从每剂100美元削减到每剂5美元。

    He said one aim would be to cut the cost of the pneumococcal vaccine from US $ 100 per dose to US $ 5 per dose .

  9. 肺炎球菌疫苗作为预防肺炎球菌病最关键的一类药物,其使用得到了越来越多的重视。

    As pneumococcal vaccine became the most key of a type of medicine to prevent from the pneumococcal disease , its usage got more and more attention .

  10. 去年,意大利,英国,加拿大,俄罗斯和挪威政府与比尔与梅琳达盖茨基金会联合提供了15亿美元发动了肺炎球菌疫苗项目。

    Last year , the governments of Italy , the United Kingdom , Canada , Russia and Norway joined with the Bill and Melinda Gates Foundation . They provided one and a half billion dollars to launch the pneumococcal vaccine project .

  11. 不只是x奖和千禧年数学问题奖,就连肺炎球菌病毒疫苗奖也有一部分资金是由私人资本提供的。

    Not only the X prizes and the Millennium problems prize , but even the pneumococcal vaccine prize is part-funded by private money .

  12. 应免疫战略咨询专家组(SAGE)要求,委员会评审了肺炎球菌结合疫苗的安全性。

    At the request of SAGE , the committee reviewed the safety of pneumococcal conjugate vaccines .

  13. 肺炎球菌结合疫苗诱导的抗荚膜多糖抗体活性研究

    Activity of Antibody to Capsular Polysaccharide Induced by Pneumococcal Conjugate Vaccine

  14. 肺炎球菌结合疫苗的安全性

    Safety of pneumococcal conjugate vaccine

  15. 会议期间完成并介绍了有关肺炎球菌结合疫苗安全性所有证据的综合性评述。

    A comprehensive review of all evidence on the safety of pneumococcal conjugate vaccines was conducted and presented .

  16. 关于7价肺炎球菌结合疫苗和其他肺炎球菌结合疫苗的安全性证据是可靠的。

    The evidence on the safety of the7-valent pneumococcal conjugate vaccine and other pneumococcal conjugate vaccines is reassuring .

  17. 试验结果表明,在接种肺炎球菌结合疫苗的一组儿童中

    Results of the trial indicated that in the group of children who received pneumococcal conjugate vaccine , there were

  18. 论文作者的结论是,应尽早向非洲婴儿提供肺炎球菌结合疫苗。

    The authors of the paper conclude that pneumococcal conjugate vaccines should be made available as soon as possible to African infants .

  19. 两家主要的制药公司已经同意为世界上最贫困的国家提供廉价的肺炎球菌疾病疫苗。

    Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world 's poorest countries at a reduced price .

  20. 目前国内已研制出肺炎球菌结合疫苗,但其使用的蛋白载体为破伤风类毒素或白喉类毒素,在将来的临床运用中可能会面临与破伤风疫苗或白喉疫苗冲突等问题。

    At present , the protein-polysaccharide conjugate pneumococcal vaccine has been developed in China . However , tetanus toxoid ( TT ) or diphtheria toxoid ( DT ) was regular used as protein carrier in general .

  21. 肺炎球菌多糖疫苗在两组中同样有效。

    The pneumococcal polysaccharide vaccine was equally effective in both groups .

  22. 23价肺炎球菌多糖疫苗预防老年人下呼吸道感染的效果考察

    Effectiveness of 23-valent Pneumococcal Polysaccharide Vaccine to Prevent LRTIs in the Elderly Population

  23. 支气管扩张病例应用23价肺炎球菌多糖疫苗的临床观察

    Clinical observation on the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients

  24. 目的:探讨23价肺炎球菌多糖疫苗在支气管扩张患者的临床意义。

    Objective : To investigate clinical significance in the application of 23-valent pneumococcus polysaccharide vaccine in bronchiectatic patients .

  25. 肺炎球菌多糖疫苗对老龄大鼠肺组织-防御素-2表达的影响

    Study of β - defensin-2 Gene Expression in the Pulmonary Tissue of the Older Rat Stimulated by Pneumococcal Vaccine Polyvalent

  26. 肺炎球菌病毒的疫苗每一剂是3.5美元,而轮状病毒疫苗是每剂7美元。

    The vaccine against pneumococcal disease costs about $ 3.50 per dose , while the rotavirus vaccine costs about $ 7.00 per dose .

  27. 在这个研究中,340名孕妇在孕期第三个三个月中被随机的分配接受灭活流感疫苗或者23-价肺炎球菌多糖疫苗注射(对照)。

    In this study , 340 pregnant women in the third trimester were randomly assigned to receive inactivated influenza vaccine or the23-valent pneumococcal polysaccharide vaccine ( control ) .

  28. 结论:23价肺炎球菌多糖疫苗能有效地减少支气管扩张患者肺部感染复发率,是临床佐治支气管扩张患者的一个有效方法,值得临床推广。

    Conclusion : 23-valent pneumococcus polysaccharide vaccine could effectively reduce recurrent rate of pulmonary infection in bronchiectatic patients . Therefore , it might be an effective adjuvant for the treatment of bronchiectasis , which is worth extending its clinical application .